2021 ISHEN guidelines on animal models of hepatic encephalopathy. (11th May 2021)

• Record Type: Journal Article
• Authors: DeMorrow, Sharon; Cudalbu, Cristina; Davies, Nathan; Jayakumar, Arumugam R.; Rose, Christopher F.
• Is Part Of: Liver international. Volume 41:Number 7(2021)
• Page Start: 1474
• Page End: 1488
• Publication Date: 2021-05-11
• Subjects: acute liver failure -- behaviour -- bile duct ligation -- chronic liver disease -- hepatic encephalopathy -- hyperammonemia -- liver toxins -- neurological deficits -- portocaval anastomosis; Liver -- Periodicals; Liver -- Diseases -- Periodicals; 616.362
• DOI: 10.1111/liv.14911
• Languages: English
• ISSNs: 1478-3223

Abstract

Abstract: This working group of the International Society of Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) was commissioned to summarize and update current efforts in the development and characterization of animal models of hepatic encephalopathy (HE). As defined in humans, HE in animal models is based on the underlying degree and severity of liver pathology. Although hyperammonemia remains the key focus in the pathogenesis of HE, other factors associated with HE have been identified, together with recommended animal models, to help explore the pathogenesis and pathophysiological mechanisms of HE. While numerous methods to induce liver failure and disease exist, less have been characterized with neurological and neurobehavioural impairments. Moreover, there still remains a paucity of adequate animal models of Type C HE induced by alcohol, viruses and non‐alcoholic fatty liver disease; the most common etiologies of chronic liver disease.